Vancouver, B.C., Sept 30, 2020 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSX-V:SVS), The company is pleased to announce that it has produced commercial volumes of its organic Omega-3 powdered supplement, using European manufacturing contractors....
Read our most recent articles and announcements
Solarvest is pleased to announce the resumption of its activities and drive to commercial production.
Solarvest BioEnergy amends deal with FSD Pharma to accelerate progress of CBD project. The project is determining if its algal expression system can create pharmaceutical-grade cannabinoids; if successful, the process could significantly reduce cannabinoid production time.